Related references
Note: Only part of the references are listed.Efficacy of short pulse and conventional deep brain stimulation in Parkinson's disease: a systematic review and meta-analysis
Xinyang Zou et al.
NEUROLOGICAL SCIENCES (2023)
Levodopa Response in Patients With Early Parkinson Disease Further Observations of the LEAP Study
Henrieke L. Frequin et al.
NEUROLOGY (2023)
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial
Jean-Christophe Corvol et al.
MOVEMENT DISORDERS (2022)
Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future
Yu-Yan Tan et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy The PD MED Randomized Clinical Trial
Richard Gray et al.
JAMA NEUROLOGY (2022)
Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson's disease patients
Gen Li et al.
TRANSLATIONAL NEURODEGENERATION (2022)
Effectiveness of Wii sports- based strategy training in reducing risk of falling, falls and improving quality of life in adults with idiopathic Parkinson's disease- a randomized comparative trial
G. Alagumoorthi et al.
CLINICAL REHABILITATION (2022)
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study
Valerie Cochen De Cock et al.
LANCET NEUROLOGY (2022)
Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients
Eva Thijssen et al.
PARKINSONISM & RELATED DISORDERS (2022)
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
Kevin McFarthing et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Dance Rhythms Improve Motor Symptoms in Individuals with Parkinson's Disease: A Randomized Clinical Trial
Jessica Amaro Moratelli et al.
JOURNAL OF DANCE MEDICINE & SCIENCE (2022)
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
Michael J Soileau et al.
LANCET NEUROLOGY (2022)
Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial
Fatemeh Hadi et al.
NEUROLOGICAL SCIENCES (2022)
Trial of Prasinezumab in Early-Stage Parkinson's Disease
G. Pagano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Trial of Cinpanemab in Early Parkinson's Disease
A. E. Lang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Worldwide trends in mortality related to Parkinson's disease in the period of 1994-2019: Analysis of vital registration data from the WHO Mortality Database
Ioannis C. Lampropoulos et al.
FRONTIERS IN NEUROLOGY (2022)
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease: A Randomized Controlled Trial
Michael Camilleri et al.
ANNALS OF INTERNAL MEDICINE (2022)
Directional Leads for Deep Brain Stimulation: Technical Notes and Experiences
Patrick Fricke et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2021)
Amantadine in the treatment of Parkinson's disease and other movement disorders
Olivier Rascol et al.
LANCET NEUROLOGY (2021)
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
Nir Giladi et al.
PARKINSONISM & RELATED DISORDERS (2021)
Dose optimization of apomorphine sublingual film for treating OFF episodes in Parkinson's disease*
C. Warren Olanow et al.
PARKINSONISM & RELATED DISORDERS (2021)
Expiratory Muscle Strength Training for Therapy of Pharyngeal Dysphagia in Parkinson's Disease
Inga Claus et al.
MOVEMENT DISORDERS (2021)
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
Regina Katzenschlager et al.
PARKINSONISM & RELATED DISORDERS (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
Carlos M. O. de Almeida et al.
MOVEMENT DISORDERS (2021)
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial
Aleksandar Videnovic et al.
MOVEMENT DISORDERS (2021)
Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial
Eric Freire-Alvarez et al.
MOVEMENT DISORDERS (2021)
Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint
Alfons Schnitzler et al.
NEUROMODULATION (2021)
Short Pulse and Conventional Deep Brain Stimulation Equally Improve the Parkinsonian Gait Disorder
Aline Seger et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
Robert A. Hauser et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Subthalamic and pallidal deep brain stimulation for Parkinson's disease-meta-analysis of outcomes
M. Lenard Lachenmayer et al.
NPJ PARKINSONS DISEASE (2021)
Yoga Meditation Enhances Proprioception and Balance in Individuals Diagnosed With Parkinson's Disease
Nicholas P. Cherup et al.
PERCEPTUAL AND MOTOR SKILLS (2021)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
C. Warren Olanow et al.
LANCET NEUROLOGY (2020)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations
Nishit B. Modi et al.
CLINICAL NEUROPHARMACOLOGY (2019)
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations
Federico Carbone et al.
CNS DRUGS (2019)
International Parkinson and Movement Disorder Society Evidence-Based Medicine Review: Update on Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2018)
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Regina Katzenschlager et al.
LANCET NEUROLOGY (2018)
Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis
Michelle N. McDonnell et al.
CLINICAL REHABILITATION (2018)
Management of constipation in patients with Parkinson's disease
Anna J. Pedrosa Carrasco et al.
NPJ PARKINSONS DISEASE (2018)
Pathological α-Synuclein in Gastrointestinal Tissues from Prodromal Parkinson Disease Patients
Morten Gersel Stokholm et al.
ANNALS OF NEUROLOGY (2016)
Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease.: Systematic review and meta-analysis
Tiago Martins Rodrigues et al.
PARKINSONISM & RELATED DISORDERS (2016)
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
Hubert H. Fernandez et al.
MOVEMENT DISORDERS (2015)
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised
Richard Gray et al.
LANCET (2014)
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
W. G. Ondo et al.
NEUROLOGY (2012)
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
Roberta Zangaglia et al.
MOVEMENT DISORDERS (2007)
Sleep-related problems of Parkinson's disease
V Dhawan et al.
AGE AND AGEING (2006)
Clozapine improves dyskinesias in Parkinson disease - A double-blind, placebo-controlled study
F Durif et al.
NEUROLOGY (2004)